New Hire and Promotion at Gemstone Bio!
Gemstone Biotherapeutics, a biotech company developing novel, bioengineered products for scar-free skin regeneration, today announced that Dr. Emily English has been named Chief Executive Officer and Heather Keith has joined the company as Director of Sales and...
Gemstone secures $300k in non-dilutive funding from TEDCO MD Stem Cell Fund
Press Release
Gemstone Biotherapeutics Awarded Grant from National Science Foundation
Baltimore-based Biotech Startup Receives Seed Funding to Support Commercialization BALTIMORE – June 22, 2018 – Gemstone Biotherapeutics, a Baltimore-based startup committed to developing technologies for skin regeneration, was awarded a Phase I Small Business...
Janty Shoga Joins Gemstone Biotherapeutics as Research Engineer
Janty Shoga joined the Gemstone Biotherapeutics team as research engineer in November of 2017. In this role, Janty contributes to the entire portfolio of skin regeneration solutions. He has extensive wetlab, microscopy and prototyping experience. With a Bachelor’s...
Gemstone Adds Drs. Teresa Compton, Ron Sherman, and Marc Dauer to Scientific Advisory Board
Gemstone is excited to welcome Teresa Compton, PhD, Ronald Sherman, DPM, and Marc Dauer, MD, as members of the scientific advisory board. Dr. Compton, former VP of Translational Medicine and Virology for Biogen Idec and former Executive Director at Novartis, brings...
Topical Gel Speeds Wound Healing
Gemstone inventors, Drs. Abadir and Walston, published in the Journal of Investigative Dermatology that a common class of medications block inflammation pathways and speeds healing of chronic wounds when applied topically. “The FDA has not issued any new drug approval for wound healing in the past 10 years,” says Abadir. “…we think we have shown that this class of medicines holds great promise in effectively healing chronic wounds that are prevalent in diabetic and aged patients.”